Desq Long
Sign in

Company

Iambic Therapeutics, Inc.

IAM · CIK 0001997038

SEC FORM 4
$0.00

Iambic Therapeutics, Inc. (IAM)

Acquisition (code A) of 28,400 shares at $0 per share.

Reporting Person Secora Michael · Officer Title CFO & Chief Corp Dev Ofcr · Transaction Code A

Traded Oct 14, 2026 · Disclosed Oct 16, 2026

Source: SEC Form 4 · 0001855980-26-000007 · filed 2026-10-16 · View filing →

SEC FORM 4
$0.00

Iambic Therapeutics, Inc. (IAM)

Acquisition (code A) of 31,000 shares at $0 per share.

Reporting Person Josephson Neil · Officer Title Chief Medical Officer · Transaction Code A

Traded Oct 14, 2026 · Disclosed Oct 16, 2026

Source: SEC Form 4 · 0001864141-26-000007 · filed 2026-10-16 · View filing →

SEC FORM 4
$0.00

Iambic Therapeutics, Inc. (IAM)

Acquisition (code A) of 132,200 shares at $0 per share.

Reporting Person Miller Thomas F. · Officer Title Chief Executive Officer · Transaction Code A

Traded Oct 14, 2026 · Disclosed Oct 16, 2026

Source: SEC Form 4 · 0002034921-26-000007 · filed 2026-10-16 · View filing →

SEC FORM 4
$0.00

Iambic Therapeutics, Inc. (IAM)

Acquisition (code A) of 19,500 shares at $0 per share.

Reporting Person Olson Peter A · Officer Title Chief Scientific Officer · Transaction Code A

Traded Oct 14, 2026 · Disclosed Oct 16, 2026

Source: SEC Form 4 · 0002155824-26-000005 · filed 2026-10-16 · View filing →

SEC FORM 4
$0.00

Iambic Therapeutics, Inc. (IAM)

Acquisition (code A) of 132,200 shares at $0 per share.

Reporting Person Manby Frederick R · Officer Title Chief Technology Officer · Transaction Code A

Traded Oct 14, 2026 · Disclosed Oct 16, 2026

Source: SEC Form 4 · 0002156015-26-000005 · filed 2026-10-16 · View filing →